- Home
- NRSN vs JFB Comparison
NRSN vs JFB Comparison
Compare NRSN & JFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- JFB
- Stock Information
- Founded
- NRSN 2017
- JFB 2014
- Country
- NRSN Israel
- JFB United States
- Employees
- NRSN N/A
- JFB N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- JFB
- Sector
- NRSN Health Care
- JFB
- Exchange
- NRSN Nasdaq
- JFB NYSE
- Market Cap
- NRSN 45.3M
- JFB 49.5M
- IPO Year
- NRSN 2021
- JFB 2025
- Fundamental
- Price
- NRSN $1.91
- JFB $7.01
- Analyst Decision
- NRSN Buy
- JFB
- Analyst Count
- NRSN 2
- JFB 0
- Target Price
- NRSN $14.00
- JFB N/A
- AVG Volume (30 Days)
- NRSN 427.0K
- JFB 29.3K
- Earning Date
- NRSN 07-15-2025
- JFB 08-11-2025
- Dividend Yield
- NRSN N/A
- JFB N/A
- EPS Growth
- NRSN N/A
- JFB N/A
- EPS
- NRSN N/A
- JFB 0.00
- Revenue
- NRSN N/A
- JFB $25,946,544.00
- Revenue This Year
- NRSN N/A
- JFB N/A
- Revenue Next Year
- NRSN N/A
- JFB N/A
- P/E Ratio
- NRSN N/A
- JFB $1,805.34
- Revenue Growth
- NRSN N/A
- JFB N/A
- 52 Week Low
- NRSN $0.51
- JFB $3.39
- 52 Week High
- NRSN $2.60
- JFB $7.40
- Technical
- Relative Strength Index (RSI)
- NRSN 48.94
- JFB N/A
- Support Level
- NRSN $1.81
- JFB N/A
- Resistance Level
- NRSN $1.96
- JFB N/A
- Average True Range (ATR)
- NRSN 0.20
- JFB 0.00
- MACD
- NRSN -0.08
- JFB 0.00
- Stochastic Oscillator
- NRSN 19.10
- JFB 0.00
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About JFB JFB CONSTRUCTION HOLDINGS
JFB Construction Holdings is a commercial and residential real estate construction and development company. It is engaged in retail corporate buildouts, multifamily community developments and luxury residential homes, with a focus on fostering long-term relationships with clients, partners, and communities. The company operates in three distinct business segments: Commercial Construction, Residential Construction, and Real Estate Development. Key revenue is generated from Commercial Construction: This segment includes all activities related to the construction of commercial properties such as office buildings, retail spaces, and industrial facilities.